Application 761201

Type
BLA
Sponsor
MYLAN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SEMGLEEINSULIN GLARGINE-YFGNINJECTABLE;INJECTION10ML(100UNITS/ML)NoNo
002SEMGLEEINSULIN GLARGINE-YFGNINJECTABLE;INJECTION3ML(100UNITS/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
49502-250SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-250SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-250SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-250SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-251SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-251SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-251SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-251SEMGLEEinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-393Insulin Glargineinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-393Insulin Glargineinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-393Insulin Glargineinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-394Insulin Glargineinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-394Insulin Glargineinsulin glargine-yfgnMylan Specialty L.P.BLACurrent
49502-394Insulin Glargineinsulin glargine-yfgnMylan Specialty L.P.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80430SUPPL 2024-11-26
80419SUPPL 2024-11-26
76704SUPPL 2023-11-30
76700SUPPL 2023-11-30
74412SUPPL 2023-05-31
74410SUPPL 2023-05-31
68528ORIG2021-09-02
68218ORIG2021-07-29
68217ORIG2021-07-28